Related Experiment Video
Updated: May 25, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1)
Seon Sook Kim1, Yohan Oh, Kwang Chul Chung
1Department of Molecular Bioscience, College of Biomedical Science, Kangwon National University, Chuncheon 200-701, Republic of Korea.
Abstract:
The Down syndrome critical region 1 (DSCR1) gene encodes a regulator of the calcineurin 1 (RCAN1) protein, and the elevated levels of RCAN1 are associated with Alzheimer's disease (AD) and Down syndrome (DS). In this report, we found that protein kinase A (PKA) was able to phosphorylate RCAN1 in vitro and in vivo. In addition, we found that the phosphorylation of RCAN1 by PKA caused an increase of RCAN1 expression by increasing of the half-life of the protein. Consistently, the pharmacological inhibition of intracellular PKA using H-89 and the knockdown of the endogenous PKA catalytic subunit with siRNA decreased the expression of RCAN1. Furthermore, the phosphorylation of RCAN1 by PKA enhanced the inhibitory function of RCAN1 on calcineurin-mediated gene transcription. Our data provide the first evidence that PKA acts as an important regulatory component in the control of RCAN1 function through phosphorylation.
Insights
Protein kinase A (PKA) phosphorylates regulator of calcineurin 1 (RCAN1), increasing its expression and enhancing its function. This discovery sheds light on RCAN1 regulation in Alzheimer's disease and Down syndrome.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Regulator of calcineurin 1 (RCAN1) protein levels are elevated in Alzheimer's disease (AD) and Down syndrome (DS).
- RCAN1 is encoded by the Down syndrome critical region 1 (DSCR1) gene.
- The precise regulatory mechanisms controlling RCAN1 expression and function remain incompletely understood.
Purpose of the Study:
- To investigate the role of protein kinase A (PKA) in the regulation of RCAN1.
- To elucidate the impact of PKA-mediated phosphorylation on RCAN1 expression and function.
- To explore the implications for calcineurin-mediated gene transcription.
Main Methods:
- In vitro and in vivo phosphorylation assays of RCAN1 by PKA.
- Pharmacological inhibition of PKA using H-89.
- siRNA-mediated knockdown of the PKA catalytic subunit.
- Analysis of RCAN1 protein half-life and expression levels.
- Assessment of RCAN1's inhibitory effect on calcineurin-mediated transcription.
Main Results:
- PKA directly phosphorylates RCAN1 both in vitro and in vivo.
- PKA-mediated phosphorylation increases RCAN1 expression by extending its protein half-life.
- Inhibition or knockdown of PKA leads to decreased RCAN1 expression.
- Phosphorylated RCAN1 exhibits enhanced inhibition of calcineurin-mediated gene transcription.
Conclusions:
- PKA is a key regulator of RCAN1 function through direct phosphorylation.
- PKA-dependent phosphorylation stabilizes RCAN1, increasing its expression and activity.
- These findings establish PKA as a critical component in the regulatory network controlling RCAN1.
More Related Videos
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Related Concept Videos
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Anaphase Promoting Complex